Clinical Trials Directory

Trials / Completed

CompletedNCT01553305

A Study of the Effect of Supervised Exercise Programme in Patients With Rheumatoid Arthritis

The Effect of 6-weeks Supervised Exercise Programme Followed by 6-weeks Unsupervised Exercise Programme Versus 12 Weeks Unsupervised Exercise Programme in Patients With Rheumatoid Arthritis.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
52 (actual)
Sponsor
Aarhus University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the effectiveness of a supervised high-intensity exercise programme followed by an unsupervised exercise programme to an unsupervised exercise programme in patients with Rheumatoid Arthritis.

Detailed description

Patients with Rheumatoid Arthritis are in general less fit and more at risk of comorbidities such as cardiovascular events compared with healthy age-matched controls. Studies indicates that patients with Rheumatoid Arthritis have a lower level of physical activity than the general population and a low proportion of patients with Rheumatoid Arthritis exercises. Regular exercise with moderate to high intensity level of intensity has proven to be effective in reducing the cardiovascular risk by improving cardiovascular fitness and to increase muscle strength. Therefore, it is of interest to investigate if supervised exercise programme makes a difference making patients with Rheumatoid Arthritis participate in exercise.

Conditions

Interventions

TypeNameDescription
OTHERSupervised high-intensity exercise programmeSix-weeks supervised high-intensity muscle strength training and physical fitness with training sessions twice a week followed by 6-weeks unsupervised high-intensity exercise programme.
OTHERExercise programmeSupervised exercise programme

Timeline

Start date
2012-01-01
Primary completion
2013-07-01
Completion
2013-07-01
First posted
2012-03-14
Last updated
2013-07-04

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01553305. Inclusion in this directory is not an endorsement.